Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study

Article Dermatology

Statin Use and Skin Cancer Risk: A Prospective Cohort Study

Marie Al Rahmoun et al.

Summary: The use of statins was not found to be associated with an increased risk of melanoma or squamous cell carcinoma, but was associated with a decreased risk of basal cell carcinoma.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Add to Collection

Article Clinical Neurology

Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies

Indu Subramanian et al.

Summary: Personalized medicine considering sex, gender, and cultural context is at the forefront of healthcare delivery. However, women's issues in Parkinson disease (PD), particularly from a psychosocial perspective, have been overlooked. Research areas include inclusive drug and device studies, genetic and hormonal considerations. Women with PD need education and empowerment to communicate their symptoms and needs, engage in research, form communities, and support each other. Clinicians treating women with PD need core competencies to accurately diagnose and treat symptoms, and ensure timely referral.

MOVEMENT DISORDERS (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies

Elena Olmastroni et al.

Summary: The meta-analysis found that statin use was associated with a decreased risk of dementia and Alzheimer's disease. There was no difference in dementia risk reduction between men and women. High-potency statins may be more effective in reducing dementia risk compared to low-potency statins.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Article Neurosciences

Parkinson's Disease Progression and Statins: Hydrophobicity Matters

Mechelle M. Lewis et al.

Summary: This study suggests that hydrophilic statins, but not lipophilic statins, may be associated with faster progression of Parkinson's disease. Further research is needed to better understand the clinical implications of these findings.

JOURNAL OF PARKINSONS DISEASE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Incidence of Parkinson's disease in French women from the E3N cohort study over 27 years of follow-up

Marianne Canonico et al.

Summary: This study estimated the incidence rates of Parkinson's disease in French women over a 27-year follow-up and found a stable incidence from 2002 to 2018. The long follow-up and large sample size make this study a valuable resource to improve our knowledge of Parkinson's disease etiology in women.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2022)

Add to Collection

Article Clinical Neurology

Path to Parkinson Disease Prevention Conclusion and Outlook

Daniela Berg et al.

Summary: Significant progress in the understanding of the pathophysiology and clinical manifestations of the prodromal phase of Parkinson disease has opened up possibilities for early therapeutic interventions. However, challenges remain in the design of prevention trials.

NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease A Randomized Clinical Trial

Kara N. Stevens et al.

Summary: Current treatments for Parkinson's disease only manage symptoms and do not slow disease progression. This study investigated whether simvastatin could be a potential disease-modifying treatment for patients with moderate PD.

JAMA NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study

Yangfan Zhao et al.

Summary: Parkinson's disease affects millions of people worldwide, and modifiable risk factors, including low-density lipoprotein cholesterol (LDL-C), may play a role. We conducted various analyses and found no evidence of a causal relationship between LDL-C levels and PD risk. Sex-specific causal inference techniques can provide insights into different contributions to disease risk between sexes.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease

Chin-Hsien Lin et al.

Summary: Evidence suggests that lovastatin may slow the progression of motor symptoms in patients with early-stage PD, especially in the striatal region. The treatment was generally well tolerated, indicating the potential benefits of lovastatin in PD management.

MOVEMENT DISORDERS (2021)

Add to Collection

Article Medicine, Research & Experimental

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe

Federico Rea et al.

Summary: Patients who were prescribed a single-pill combination of statin/ezetimibe were more likely to exhibit good adherence and less likely to have poor adherence to treatment compared to those prescribed a two-pill combination. This was associated with a decreased risk of cardiovascular events in patients with high adherence.

ADVANCES IN THERAPY (2021)

Add to Collection

Article Neurosciences

Statins in Parkinson's Disease: Influence on Motor Progression

Giovanni Palermo et al.

Summary: The study found that long-term statin use in patients with Parkinson's disease can slow down the progression of motor impairment, especially after 4 years. Statin treatment also resulted in a slower progression of the rigidity score of UPDRS compared to non-users.

JOURNAL OF PARKINSONS DISEASE (2021)

Add to Collection

Article Medicine, General & Internal

A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes

Ge Liu et al.

Summary: This study utilized a genetic risk score method to examine the association between HMGCR gene variants and statin use, finding a significant link only with type 2 diabetes. There was limited evidence for pleiotropic effects of statin-induced decrease in low-density lipoprotein cholesterol levels on other diseases.

JAMA NETWORK OPEN (2021)

Add to Collection

Review Neurosciences

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease

Julia L. Y. Cheong et al.

JOURNAL OF PARKINSONS DISEASE (2020)

Add to Collection

Review Clinical Neurology

Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis

Zheng Jiang et al.

FRONTIERS IN NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Evaluating Lipid-Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization

Dylan M. Williams et al.

ANNALS OF NEUROLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Effect of statins on Parkinson's disease A systematic review and meta-analysis

Junqiang Yan et al.

MEDICINE (2019)

Add to Collection

Article Clinical Neurology

Association of statin use with Parkinson's disease: Dose-response relationship

Su-Min Jeong et al.

MOVEMENT DISORDERS (2019)

Add to Collection

Review Neurosciences

Statins and the Brain: More than Lipid Lowering Agents?

Anna Fracassi et al.

CURRENT NEUROPHARMACOLOGY (2019)

Add to Collection

Review Public, Environmental & Occupational Health

Methods for time-varying exposure related problems in pharmacoepidemiology: An overview

Laura Pazzagli et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)

Add to Collection

Article Clinical Neurology

Use of medical care biases associations between Parkinson disease and other medical conditions

Anat Gross et al.

NEUROLOGY (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis

Katsiaryna Bykov et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Add to Collection

Article Public, Environmental & Occupational Health

Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies

Tahmina Nasrin Poly et al.

NEUROEPIDEMIOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Statin adherence and the risk of Parkinson's disease: A population-based cohort study

Violetta Rozani et al.

PLOS ONE (2017)

Add to Collection

Article Clinical Neurology

Statin Therapy Prevents the Onset of Parkinson Disease in Patients with Diabetes

Kun-Der Lin et al.

ANNALS OF NEUROLOGY (2016)

Add to Collection

Article Behavioral Sciences

Statin use and risk of Parkinson's disease: A meta-analysis

Zhiguo Sheng et al.

BEHAVIOURAL BRAIN RESEARCH (2016)

Add to Collection

Review Clinical Neurology

Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses

Vanesa Bellou et al.

PARKINSONISM & RELATED DISORDERS (2016)

Add to Collection

Article Clinical Neurology

Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology

A. Elbaz

REVUE NEUROLOGIQUE (2016)

Add to Collection

Article Multidisciplinary Sciences

Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis

Shuang Bai et al.

PLOS ONE (2016)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

Jordan Fulcher et al.

LANCET (2015)

Add to Collection

Article Clinical Neurology

Statins, Plasma Cholesterol, and Risk of Parkinson's Disease: A Prospective Study

Xuemei Huang et al.

MOVEMENT DISORDERS (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Cohort Profile: The French E3N Cohort Study

Francoise Clavel-Chapelon

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)

Add to Collection

Letter Public, Environmental & Occupational Health

Generalizability of Occupational Cohort Study Findings

G. David Batty et al.

EPIDEMIOLOGY (2014)

Add to Collection

Article Chemistry, Medicinal

Statins in therapy: Understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies

Clifford W. Fong

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Why representativeness should be avoided

Kenneth J. Rothman et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)

Add to Collection

Article Clinical Neurology

Statin use and risk of Parkinson's disease: a meta-analysis of observational studies

Krishna Undela et al.

JOURNAL OF NEUROLOGY (2013)

Add to Collection

Article Clinical Neurology

Discontinuation of statin therapy associates with Parkinson disease A population-based study

Yen-Chieh Lee et al.

NEUROLOGY (2013)

Add to Collection

Article Clinical Neurology

Prospective Study of Statin Use and Risk of Parkinson Disease

Xiang Gao et al.

ARCHIVES OF NEUROLOGY (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Meta-Analysis of Statin Effects in Women Versus Men

William J. Kostis et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Add to Collection

Article Public, Environmental & Occupational Health

Prediction Model of Parkinson's Disease Based on Antiparkinsonian Drug Claims

Frederic Moisan et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)

Add to Collection

Article Clinical Neurology

Prospects of Statins in Parkinson Disease

Avik Roy et al.

NEUROSCIENTIST (2011)

Add to Collection

Article Economics

The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults

Amanda R. Patrick et al.

VALUE IN HEALTH (2011)

Add to Collection

Article

When Does Parkinson Disease Start?

Rodolfo Savica et al.

ARCHIVES OF NEUROLOGY (2010)

Add to Collection

Article Medicine, General & Internal

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

Julia Hippisley-Cox et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Add to Collection

Article Public, Environmental & Occupational Health

Immortal time bias in pharmacoepidemiology

Samy Suissa

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

Add to Collection

Article Clinical Neurology

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease

Kelly Claire Simon et al.

NEUROLOGY (2007)

Add to Collection

Letter Clinical Neurology

Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson Disease

Lonneke M. L. de Lau et al.

MOVEMENT DISORDERS (2007)

Add to Collection

Article Medicine, General & Internal

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

Benjamin Wolozin et al.

BMC MEDICINE (2007)

Add to Collection

Article Pharmacology & Pharmacy

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

M Schachter

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)

Add to Collection

Article Mathematical & Computational Biology

Choice of time-scale in Cox's model analysis of epidemiologic cohort data:: a simulation study

ACM Thiébaut et al.

STATISTICS IN MEDICINE (2004)

Add to Collection

Article Public, Environmental & Occupational Health

Evaluating medication effects outside of clinical trials: New-user designs

WA Ray

AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)

Add to Collection

Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study

Related references

Export Citation

Share Paper